Janus Henderson Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
|
|||||
|
2025
Q1 | $12.8M | Buy |
|
|||||
|
2024
Q4 | $8.34M | Buy |
|
|||||
|
2024
Q3 | $2.69M | Buy |
|
|||||
|
2024
Q2 | $448K | Sell |
|
|||||
|
2024
Q1 | $21.9M | Sell |
|
|||||
|
2023
Q4 | $19.3M | Sell |
|
|||||
|
2023
Q3 | $19.7M | Sell |
|
|||||
|
2023
Q2 | $23.1M | Sell |
|
|||||
|
2023
Q1 | $30.7M | Sell |
|
|||||
|
2022
Q4 | $34.4M | Sell |
|
|||||
|
2022
Q3 | $61.4M | Buy |
|
|||||
|
2022
Q2 | $39.1M | Sell |
|
|||||
|
2022
Q1 | $48M | Sell |
|
|||||
|
2021
Q4 | $70.5M | Sell |
|
|||||
|
2021
Q3 | $80.9M | Buy |
|
|||||
|
2021
Q2 | $96.7M | Buy |
|
|||||
|
2021
Q1 | $96.6M | Sell |
|
|||||
|
2020
Q4 | $102M | Sell |
|
|||||
|
2020
Q3 | $107M | Sell |
|
|||||
|
2020
Q2 | $89.9M | Buy |
|
|||||
|
2020
Q1 | $83.3M | Buy |
|
|||||
|
2019
Q4 | $92.7M | Buy |
|
|||||
|
2019
Q3 | $49.3M | Sell |
|
|||||
|
2019
Q2 | $56.9M | Buy |
|
|||||
|
2019
Q1 | $55M | Sell |
|
|||||
|
2018
Q4 | $71.3M | Buy |
|
|||||
|
2018
Q3 | $60.7M | Buy |
|
|||||
|
2018
Q2 | $90.9M | Sell |
|
|||||
|
2018
Q1 | $97.8M | Buy |
|
|||||
|
2017
Q4 | $60.8M | Buy |
|